BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for systemic lupus erythematosus...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that AstraZeneca has added a novel target for Heart Failure to...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Dr. Joerg Moeller as Chief Executive Officer and...
BenevolentAI, a leader in the development of advanced AI that accelerates biopharma discovery, announces the appointment of Catherine Isted, ACMA, who will be joining...